Patents by Inventor Stefan Aigner

Stefan Aigner has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230108123
    Abstract: Described and featured are compositions and methods for treating developmental, neurodevelopmental (e.g., Fragile X syndrome (FXS) or Down syndrome (DS)), or neurodegenerative diseases or disorders (e.g., Alzheimer's disease (AD)) by increasing expression of Fragile X Mental Retardation Protein (FMRP) in patients having or having a propensity to develop such diseases or disorders.
    Type: Application
    Filed: March 25, 2021
    Publication date: April 6, 2023
    Applicants: The Broad Institute, Inc., The Regents of the University of California
    Inventors: Lindy BARRETT, Sara G. SUSCO, Eugene YEO, Stefan AIGNER, En-Ching LUO
  • Patent number: 11571390
    Abstract: Orally administrable pharmaceutical compositions, methods of administration, and methods of making the same are provided. The pharmaceutical compositions provide abuse deterrent properties.
    Type: Grant
    Filed: March 18, 2014
    Date of Patent: February 7, 2023
    Assignee: Othemo Life Sciences, Inc.
    Inventors: Manish S. Shah, Ray J. DiFalco, Stefan Aigner
  • Patent number: 10729685
    Abstract: Orally administrable pharmaceutical compositions and methods of administration are provided. The pharmaceutical compositions provide abuse deterrent properties.
    Type: Grant
    Filed: September 15, 2014
    Date of Patent: August 4, 2020
    Assignee: OHEMO Life Sciences Inc.
    Inventors: Manish S. Shah, Ray J. DiFalco, Stefan Aigner
  • Patent number: 10420726
    Abstract: Orally administrable pharmaceutical compositions, methods of administration, and methods of making the same are provided. The pharmaceutical compositions provide abuse deterrent properties.
    Type: Grant
    Filed: March 18, 2014
    Date of Patent: September 24, 2019
    Assignee: INSPIRION DELIVERY SCIENCES, LLC
    Inventors: Manish S. Shah, Ray J. Difalco, Stefan Aigner
  • Patent number: 9687928
    Abstract: A fixing element has a base area that is provided for the purpose of being welded to a component, and a functional head protruding from a base area that is formed by at least one spherical, or sphere-like element. The fixing element may be welded to a first component and function as a male fixing element that cooperates with a female fixing element of a second component such that the first and second components are detachably connectable via the fixing elements.
    Type: Grant
    Filed: June 16, 2014
    Date of Patent: June 27, 2017
    Assignee: Bayerische Motoren Werke Aktiengesellschaft
    Inventors: Johann Van Niekerk, Hannes Vasold, Stefan Aigner
  • Publication number: 20160074383
    Abstract: Orally administrable pharmaceutical compositions and methods of administration are provided. The pharmaceutical compositions provide abuse deterrent properties.
    Type: Application
    Filed: September 15, 2014
    Publication date: March 17, 2016
    Inventors: Manish S. Shah, Ray J. DiFalco, Stefan Aigner
  • Publication number: 20150005334
    Abstract: Orally administrable pharmaceutical compositions, methods of administration, and methods of making the same are provided. The pharmaceutical compositions provide abuse deterrent properties.
    Type: Application
    Filed: September 12, 2014
    Publication date: January 1, 2015
    Inventors: Manish S. SHAH, Ray J. DiFalco, Stefan Aigner
  • Publication number: 20140294488
    Abstract: A fixing element has a base area that is provided for the purpose of being welded to a component, and a functional head protruding from a base area that is formed by at least one spherical, or sphere-like element. The fixing element may be welded to a first component and function as a male fixing element that cooperates with a female fixing element of a second component such that the first and second components are detachably connectable via the fixing elements.
    Type: Application
    Filed: June 16, 2014
    Publication date: October 2, 2014
    Inventors: Johann VAN NIEKERK, Hannes VASOLD, Stefan AIGNER
  • Publication number: 20140275150
    Abstract: Orally administrable pharmaceutical compositions, methods of administration, and methods of making the same are provided. The pharmaceutical compositions provide abuse deterrent properties.
    Type: Application
    Filed: March 18, 2014
    Publication date: September 18, 2014
    Applicant: Inspirion Delivery Technologies, LLC
    Inventors: Manish S. Shah, Ray J. DiFalco, Stefan Aigner
  • Publication number: 20140275038
    Abstract: Orally administrable pharmaceutical compositions, methods of administration, and methods of making the same are provided. The pharmaceutical compositions provide abuse deterrent properties.
    Type: Application
    Filed: March 18, 2014
    Publication date: September 18, 2014
    Applicant: Inspirion Delivery Technologies, LLC
    Inventors: Manish S. Shah, Ray J. DiFalco, Stefan Aigner
  • Publication number: 20140275149
    Abstract: Orally administrable pharmaceutical compositions, methods of administration, and methods of making the same are provided. The pharmaceutical compositions provide abuse deterrent properties.
    Type: Application
    Filed: March 18, 2014
    Publication date: September 18, 2014
    Applicant: Inspirion Delivery Technologies, LLC
    Inventors: Manish S. Shah, Ray J. DiFalco, Stefan Aigner
  • Publication number: 20140271898
    Abstract: Orally administrable pharmaceutical compositions, methods of administration, and methods of making the same are provided. The pharmaceutical compositions provide abuse deterrent properties.
    Type: Application
    Filed: March 18, 2014
    Publication date: September 18, 2014
    Applicant: Inspirion Delivery Technologies, LLC
    Inventors: Manish S. Shah, Ray J. DiFalco, Stefan Aigner
  • Publication number: 20140275039
    Abstract: Orally administrable pharmaceutical compositions, methods of administration, and methods of making the same are provided. The pharmaceutical compositions provide abuse deterrent properties.
    Type: Application
    Filed: March 18, 2014
    Publication date: September 18, 2014
    Applicant: Inspirion Delivery Technologies, LLC
    Inventors: Manish S. Shah, Ray J. DiFalco, Stefan Aigner
  • Patent number: 7917267
    Abstract: In order to determine an optimized upshift point, it is proposed that a control circuit, on the basis of a current engine operating point (TQCUR;N) calculates a new engine operating point (TQNEW; NNEW) produced when shifting up at approximately the same vehicle speed, wherein the current engine operating point is determined as the optimized upshift point if the calculated new engine operating point is below a preset upper torque limit (TQ_MAX_LIM) and is at the same time above a preset lower engine speed limit (N_MIN_x+1) for the higher gear.
    Type: Grant
    Filed: September 15, 2008
    Date of Patent: March 29, 2011
    Assignee: Continental Automotive GmbH
    Inventors: Stefan Aigner, Laurent Bailliard, Gerhard Schopp
  • Publication number: 20090076692
    Abstract: In order to determine an optimized upshift point, it is proposed that a control circuit, on the basis of a current engine operating point (TQCUR;N) calculates a new engine operating point (TQNEW; NNEW) produced when shifting up at approximately the same vehicle speed, wherein the current engine operating point is determined as the optimized upshift point if the calculated new engine operating point is below a preset upper torque limit (TQ_MAX_LIM) and is at the same time above a preset lower engine speed limit (N_MIN_x+1) for the higher gear.
    Type: Application
    Filed: September 15, 2008
    Publication date: March 19, 2009
    Inventors: Stefan Aigner, Laurent Bailliard, Gerhard Schopp